MAPT and Alzheimer disease: In humans and mice, elevated serum levels of BCAAs have been associated with AD, and leucine-rich diets have been shown to activate phospho-Tau via a mammalian target of rapamycin (mTOR)-dependent mechanism, which significantly increased the phosphorylation levels of tau in the brain tissue of AD mice (Li et al., 2018).